The next great leap in drug development will come from clinico-genomics data – But do we have the right approach?

As genomic, phenotypic and clinical data are continuously being generated at an exponential pace, the biopharma industry must find more efficient ways of accessing and working with large volumes of complex and siloed data. This is especially critical for big pharmaceutical companies that need to optimise and accelerate clinical research and drug development processes. In a recent interview with Pharma...

Recap of PopGen:Live – Behind-the-scenes of Genomics England’s revolutionary new Research Environment

National initiatives and biobanks have been driving the genomics transformation for years – however these efforts have been fraught with major challenges as biomedical data grows exponentially, including usability, commercial and security challenges. However, the greatest challenge faced by these initiatives is the fact that data is becoming more siloed and distributed than ever before.   Lifebit has launched a new...